Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1993 1
1998 2
2000 2
2001 3
2002 5
2003 1
2005 4
2006 3
2007 3
2008 11
2009 10
2010 15
2011 9
2012 8
2013 10
2014 7
2015 7
2016 9
2017 9
2018 6
2019 5
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 27269389

128 results
Results by year
Filters applied: . Clear all
Page 1
Potential drug therapies for the treatment of fibromyalgia.
Lawson K. Lawson K. Expert Opin Investig Drugs. 2016 Sep;25(9):1071-81. doi: 10.1080/13543784.2016.1197906. Epub 2016 Jun 16. Expert Opin Investig Drugs. 2016. PMID: 27269389 Review.
Pharmacotherapy of fibromyalgia.
Mease PJ, Dundon K, Sarzi-Puttini P. Mease PJ, et al. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):285-97. doi: 10.1016/j.berh.2011.01.015. Best Pract Res Clin Rheumatol. 2011. PMID: 22094202 Review.
New drugs or alternative therapy to blurring the symptoms of fibromyalgia-a patent review.
Oliveira MA, Guimarães AG, Araújo AAS, Quintans-Júnior LJ, Quintans JSS. Oliveira MA, et al. Expert Opin Ther Pat. 2017 Oct;27(10):1147-1157. doi: 10.1080/13543776.2017.1349105. Epub 2017 Jul 10. Expert Opin Ther Pat. 2017. PMID: 28665159 Review.
An update on emerging drugs for fibromyalgia treatment.
Atzeni F, Gerardi MC, Masala IF, Alciati A, Batticciotto A, Sarzi-Puttini P. Atzeni F, et al. Expert Opin Emerg Drugs. 2017 Dec;22(4):357-367. doi: 10.1080/14728214.2017.1418323. Epub 2017 Dec 19. Expert Opin Emerg Drugs. 2017. PMID: 29250975 Review.
Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study.
Bruno A, Micò U, Lorusso S, Cogliandro N, Pandolfo G, Caminiti M, Zoccali RA, Muscatello MR. Bruno A, et al. J Clin Psychopharmacol. 2013 Aug;33(4):507-11. doi: 10.1097/JCP.0b013e31829057ae. J Clin Psychopharmacol. 2013. PMID: 23764682 Clinical Trial.
Available therapies and current management of fibromyalgia: focusing on pharmacological agents.
Han C, Lee SJ, Lee SY, Seo HJ, Wang SM, Park MH, Patkar AA, Koh J, Masand PS, Pae CU. Han C, et al. Drugs Today (Barc). 2011 Jul;47(7):539-57. doi: 10.1358/dot.2011.47.7.1603503. Drugs Today (Barc). 2011. PMID: 22013561 Review.
Pharmacotherapy in fibromyalgia (FM)--implications for the underlying pathophysiology.
Schmidt-Wilcke T, Clauw DJ. Schmidt-Wilcke T, et al. Pharmacol Ther. 2010 Sep;127(3):283-94. doi: 10.1016/j.pharmthera.2010.03.002. Epub 2010 Apr 11. Pharmacol Ther. 2010. PMID: 20388527 Review.
Treatment of fibromyalgia and its symptoms.
Staud R. Staud R. Expert Opin Pharmacother. 2007 Aug;8(11):1629-42. doi: 10.1517/14656566.8.11.1629. Expert Opin Pharmacother. 2007. PMID: 17685881 Review.
Emerging pharmacological therapies for fibromyalgia.
Lawson K. Lawson K. Curr Opin Investig Drugs. 2006 Jul;7(7):631-6. Curr Opin Investig Drugs. 2006. PMID: 16869116 Review.
Emerging drugs for major depressive disorder.
Connolly KR, Thase ME. Connolly KR, et al. Expert Opin Emerg Drugs. 2012 Mar;17(1):105-26. doi: 10.1517/14728214.2012.660146. Epub 2012 Feb 20. Expert Opin Emerg Drugs. 2012. PMID: 22339643 Review.
128 results
Jump to page
Feedback